3/7/2018. Making the Most Out of Your Asthma Visit. Disclosures And Conflicts Of Interest. Outline. Michael Zacharisen, MD Allergy/Immunology
|
|
- Alannah Johns
- 6 years ago
- Views:
Transcription
1 Making the Most Out of Your Asthma Visit Michael Zacharisen, MD Allergy/Immunology Disclosures And Conflicts Of Interest Green Bay Packer fan I drive a Jeep Information today: Published studies Personal experience (25 years) and still working on it Outline Asthma Care in the Office Setting What are the roadblocks? What are the solutions? 1
2 Case Study: Asthma Follow Up Mrs. Jones brings in Bridger (7 yrs old) 6 month follow up visit: 10 min late to the visit (icy roads) Younger twin siblings with her (sick with colds and dirty diapers) Front desk: collect updated information etc. How do you make this visit work effectively and efficiently? Asthma Care Visit: Roadblocks Time (or lack of) Establishing asthma severity and control What tools to use? Treatment Using National Guidelines (out of date?) Medications Adherence Inhalers: which one? Formularies and Prior authorizations During an average day, is physician time well spent? 27%: direct clinical face-to-face time with pts 49.2%: time spent on EHRs and other work (reviewing tests, logging info, med orders) Communication with pts Portals, , fax, phone 1%: insurance and scheduling ORIGINAL RESEARCH 6 DECEMBER 2016 Allocation of Physician Time in Ambulatory Practice: A Time and Motion Study in 4 Specialties Ann Int Med
3 Asthma Visit Roadblocks: Time Average time a doctor spends with pts? 13 to 16 min* Female physicians spend more time than male doctors 52.9%: In the exam room talking with pts 37%: time spent on EHR/desk work Recording/documentation Ordering Providers: spend up to 2 hrs of personal time every night "catching up" on additional clerical work *Medscape (owned by WebMD) released 2016 Physician Compensation Report, self reported data from >19,200 doctors in 26 specialties. Time is relative! Primary care appts last <5 minutes in 18 countries that represent half the world s population In India, average visit with primary care doctor lasts: 2 minutes In Bangladesh: average visit: 48 seconds International variations in primary care physician consultation time: a systematic review of 67 countries. Irving et al. BMJ Open So much to do, so little time! Multiple tasks to accomplish: Assess severity (first visit) & control (follow up) Examination Assess co-morbidities Document lung function (>5 yrs old) Develop or change treatment plan Educate: inhaler technique, action plan Answer questions Pts may have different: beliefs, concerns and goals about treatment plan 3
4 Obtaining information: History Severe symptoms? ER, urgent care Hospitalizations Prednisone Day, night or exercise? Interfere with activity Albuterol use Controller use Other: colds Influenza vaccine Physical Exam: Weight/Growth VS with pulse ox ENT (thrush) Respiratory Skin Inhaler technique Asthma Control Test (ACT) Spirometry ( 5 yr) Annual, med changes Components of Severity Impairment Symptoms Nighttime awakenings SABA for symptom control (not prevention of EIB) Intermittent 2 days/wk Classification of Asthma Severity (0 4 years of age) Persistent Mild Moderate Severe >2 days/wk but not daily Daily Throughout the day 0 1 2x/month 3 4x/month >1x/week 2 days/wk >2 days/wk but not daily Daily Several times per day Risk Interference with normal activity None Minor limitation Exacerbations (consider frequency and severity) Recommended Step for Initiating Therapy (See figure 4-1a for treatment steps.) 0 1/year Some limitation Extremely limited 2 exacerbations in 6 months requiring oral steroids, or 4 wheezing episodes/1 year lasting >1 day AND risk factors for persistent asthma Frequency and severity may fluctuate over time Exacerbations of any severity may occur in patients in any severity category Step 1 Step 2 Step 3 and consider short course of oral steroids In 2 6 weeks, depending on severity, evaluate level of asthma control achieved. If no clear benefit in 4 6 weeks, consider adjusting therapy or alternative diagnoses. Components of Control Classification of Asthma Control (0 4 years of age) Well Controlled Not Well Controlled Very Poorly Controlled Symptoms 2 days/week >2 days/week Throughout the day Nighttime awakenings 1/month >1x/month >1x/week Impairment Interference with normal activity Short-acting beta 2-agonist use for symptom control (not prevention of EIB) None Some limitation Extremely limited 2 days/week >2 days/week Several times per day Risk Exacerbations 0 1 per year 2 3 per year >3 per year Treatment-related adverse effects Recommended Action for Treatment (See figure 4-1a for treatment steps.) Med side effects can vary in intensity from none to very troublesome. Level of intensity does not correlate to specific levels of control but should be considered in the overall assessment of risk. Maintain current treatment. Regular followup every 3 6 months. Consider step down if well controlled for at least 3 months. Step up (1 step) and Reevaluate in 2 6 weeks. If no clear benefit in 4 6 weeks, consider alternative diagnoses or adjusting therapy. For side effects, consider alternative treatment options. Consider short course of oral corticosteroids, Step up (1 2 steps), and Reevaluate in 2 wks, If no clear benefit in 4 6 wks, consider alternative diagnoses or adjusting Tx For side effects, consider alternative Rx options. 4
5 Intermittent Asthma Persistent Asthma: Daily Medication Ages 0-4 yrs Consult with asthma specialist if step 3 care or higher is required. Consider consultation at step 2. Step 2 Preferred: Step 1 Low-dose ICS Preferred: SABA PRN Alternative: Step 3 Preferred: Medium-dose ICS Step 6 Step 4 Preferred: Step 5 Preferred: High-dose ICS Preferred: High-dose ICS AND Medium-dose AND Either: ICS Either: Montelukast or AND Montelukast or LABA LABA Either: AND Montelukast or Oral corticosteroids LABA Montelukast or Cromolyn Patient Education and Environmental Control at Each Step Quick-Relief Medication for All Patients SABA as needed for symptoms. Intensity of treatment depends on severity of symptoms. With viral respiratory infection: SABA q 4 6 hours up to 24 hours (longer with physician consult). Consider short course of systemic oral corticosteroids if exacerbation is severe or patient has history of previous severe exacerbations. Caution: Frequent use of SABA may indicate the need to step up treatment. See text for recommendations on initiating daily long-term-control therapy. Step up if needed (first, check adherence and environmental control) Assess control Step down if possible (and asthma is well controlled at least 3 months) Asthma Guidelines Last publication of NHLBI, Guidelines for the Diagnosis & Treatment of Asthma: 2007 Last publication of Global Guidelines: 2017 What is new in the last 12 years? Think Back Over the Last ~12 Yrs! No iphone. Steve Jobs unveiled the first iphone in 2007 No Facebook (unless in college). Opened to public in 2006 No Twitter. Full version launched in 2006 No Instagram. Picture sharing site launched in 2010 No Uber. Company received its seed funding in 2009 No ipad. Apple started the first-gen product in
6 What s new in Asthma Medications in the Last 10 years? 2008 Alvesco (ICS) 2010 Dulera (ICS/LABA) Bronchial thermoplasty 2013 Breo Ellipta (ICS/LABA) 2014 Arnuity Ellipta (ICS) 2015 Spiriva Respimat (LAMA) Mepolizumab (Nucala) SQ 2016 Omalizumab; >6 y/o Reslizumab (Cinqair) IV 2017 AirDuo RespiClick Dupilumab (Dupixent) SQ Benralizumab (Fasenra) SQ New Devices Old Devices Jet Nebulizer Pressurized MDI Dry Powder inhaler Diskus Turbuhaler Rotahaler Ellipta New Devices RespiClick RespiMat New Features Dose counters 6
7 Time Savers! History Differentiating asthma from VCD (vocal cord dysfunction) Trouble breathing IN or OUT? Check inspiratory loop on your spirometry Time Savers! Utilize your team At check-in: Vital signs including pulse oximeter Asthma medication check: How often are you taking? Did you receive your flu shot? Administer: Asthma Control Test (ACT); If >19, normal! Spirometry Check inhaler technique Asthma Action Plan: Asthma Action Plan Green Zone: Take These Controller Medicine(s) Everyday GO Medicine Strength How much to take How often to take Budesonide Respules 1 vial Pulmicort puffs Breathing is normal: Alvesco puffs No cough, wheeze Asmanex puffs or shortness of breath Flovent puffs Can do regular activities QVAR puffs Advair puffs Peak flow more than: Dulera puffs (>80%) Symbicort puffs Montelukast 1 tablet daily Other: Albuterol 2 puffs 20 minutes before gym/activity Yellow Zone: Begin Taking Rescue Medicine(s) Caution Keep taking your controller/green zone medicine(s) Begin taking your rescue medicine as instructed below. Asthma is Uncontrolled: Medicine Strength How much to take How often to take Cough Albuterol MDI puffs Every 20 minutes x 3 Wheeze Albuterol Solution vial then 4-6 hours as needed Shortness of breath Xopenex MDI puffs Chest tightness Xopenex Solution vial Waking up at night Prednisone with food Other: Early with a cold Peak Flow is: to (50-80%) Call: If you are using your rescue medicine more than every 4 hours and symptoms not improving. Red Zone: Go to the emergency room or call 911! STOP Take Immediate Action! DANGER: Medicine How much to take How often to take Albuterol MDI puffs Every 15 minutes Medicine is not helping Albuterol solution vial on the way to the ER Breathing is hard and fast Lev-albuterol (Xopenex MDI) puffs Nasal flaring Lev-albuterol (Xopenex solution) vial Difficult walking/talking Peak flow is less than: (<50%) NHLBI Guidelines for Diagnosis & treatment of Asthma Asthma Action Plan since 1995 (23 years) Narrow window of opportunity! Use Stop Light Colors Patient: DOB: From: M. Zacharisen, MD Phone:
8 Time savers! Education No Black Box warning on ICS/LABA (Breo, Advair, Symbicort, Dulera, AirDuo) Effective Dec 2017 Unnecessary to take 10 min trying to explain why asthma meds trigger fatal asthma attacks! Time Savers! Use Posters Quick relievers vs daily controllers That s it! The red one! SABA LABA ICS ICS/LABA and LABA/LAMA LAMA and SABA/SAMA Biologicals and BT Time Saver! Use Models Review: inflammation and bronchoconstriction and degrees of severity. 8
9 Time Savers! EHR Maximize the EHR Growth charts: children on ICS/prednisone Validated surveys: Asthma Control Test E-prescribing E-order entry: labs, radiology Medical Records with customized templates for asthma notes. Education for Partnership in Asthma Care=Adherence Family will manage asthma on a daily basis Best management plan is not effective if pt doesn t adhere to the regimen Adherence=closely linked to communication and pt educ. Bender et al in ICS Adherence: by child/mother report: 80% by canister weight: 69% by electronic doser: 50% More Efficient Asthma Education During a Short Office Visit: Results from PACE Study. By Michael Cabana, MD, MPH. San Francisco Asthma Network Forum 2016 Medication Adherence: by electronic dose counters N=1394 pts over 8 wks of data for 11,155 pt-wks of data Med adherence improved with age (avg wkly adherence) <12 yr old 47% yr old 40.7% 60 yr old 65% (P<.001) Season: Highest in winter (54%); lowest in summer (35%) Most pts (70%) were Rx bid 56% adhering to both doses and 22% adhering to either am or pm. Avg adherence for ICS/LABA was 15% higher than ICS alone Hock and Szefler, AAAAI abstract #
10 Questions from parents It s not asthma, it s bronchitis/rads Diagnosis Is it hurting his lungs? Necessity It s too expensive Cost He doesn't remember to take it Adherence Will it stunt his growth Steroid concerns Will have to be on them all the time? Duration of med use He takes medications too often Frequency of med use Seems like strong meds for daily use Amount of medication Will it make him hyper? Side effects Education: Not a Time Saver but worth the investment! Lack of pt/family education: Less medication adherence Less asthma control More symptoms, less sleep, less exercise More ER or urgent visits, prednisone, hospitalizations More expensive and more steroids, more side effects Missed school or work Lower quality of life Less pt/family satisfaction Less healthcare provider satisfaction Methods for improving Communication Communication skills: Sit down, listen (non-verbal attentiveness/encouragement) Both parties need to pay attention Key messages Addressing immediate concerns: Eliciting underlying fears (steroid phobia) Reassuring messages Share similar goals of treatment Verbal praise 10
11 Key Educational messages What happens during an asthma attack How to take medicines How to respond to changes in asthma severity Safety of medicines Goals of therapy Criteria for successful treatment Managing asthma at school Identifying and avoiding triggers Sources of additional asthma education Cost and Coverage of Medications Samples: trial before Rx Formulary: constantly changing Prior Authorizations Cover My Meds Manufacturer Coupons (paper vs online) 11
12 On-line resources Dr. Google Montana Dept of Public Health Amer College Allergy, Asthma, Immunol Amer Academy Allergy, Asthma, Immunol American Lung Association Allergy & Asthma Network National Heart Lung, Blood Institute of NIH Asthma & Allergy Foundation of America WebMD Pubmed (National Library of Medicine) Mayo Clinic Grandma know it all answers your questions! Treating Asthma in 2018 Stay calm/yoga Quit smoking/vaping Eat your veggies Treat your GE reflux Avoid allergic triggers Take your meds (correctly) Maintain healthy weight Exercise 30 min Learn inhaler technique twice/week Check: IgE, CBC Take Vitamin D Monitor spirometry Get vaccinated Regular follow-up visits 12
13 Breaking down the 20 min Visit Time Inhaler technique Educ VS ACT Review Plan Spirometry Review Control Exam History Thank You to all who make my work life better! My appreciation to: My tolerant wife and business manager My dedicated medical assistants My friendly, capable medical receptionist 13
MANAGING ASTHMA. Nancy Davis, RRT, AE-C
MANAGING ASTHMA Nancy Davis, RRT, AE-C What is asthma? Asthma is a chronic respiratory disease characterized by episodes or attacks of inflammation and narrowing of small airways in response to asthma
More informationLearning the Asthma Guidelines by Case Studies
Learning the Asthma Guidelines by Case Studies Timothy Craig, DO Professor of Medicine and Pediatrics Distinguished Educator Penn State University Hershey Medical Center Objectives 1. Learn the Asthma
More informationNancy Davis, RRT, AE-C
Nancy Davis, RRT, AE-C Asthma Statistics 25.6 million Americans diagnosed with asthma 6.8 million are children 10.5 million missed school days per year 14.2 lost work days for adults Approximately 10%
More informationAsthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationImproving the Management of Asthma to Improve Patient Adherence and Outcomes
Improving the Management of Asthma to Improve Patient Adherence and Outcomes Robert Sussman, MD Atlantic Health System Overlook Medical Center Asthma Remains a Serious Health Risk in the US Every day in
More informationASTHMA IN THE PEDIATRIC POPULATION
ASTHMA IN THE PEDIATRIC POPULATION SEARCH Rotation 2 August 23, 2010 Objectives Define asthma as a chronic disease Discuss the morbidity of asthma in pediatrics Discuss a few things that a health center
More information12/18/2017. Disclosures. Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing
Asthma Management Updates: A Focus on Long-acting Muscarinic Antagonists and Intermittent Inhaled Corticosteroid Dosing Diana M. Sobieraj, PharmD, BCPS Assistant Professor University of Connecticut School
More informationPATIENT INFORMATION FORM
PATIENT INFORMATION FORM "I am going to ask you a number of questions about your asthma. The set of questions is somewhat long, but I will try to move through it fairly quickly so that we can complete
More informationAlberta Childhood Asthma Pathway for Primary Care
Asthma Diagnosis Box 1 Diagnosis: Based on symptom pattern, careful and thorough history of symptoms (wheeze, cough, night waking and activity limitations), and assessment of family history of asthma and
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
CINQAIR (reslizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationAsthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION
Asthma Management in Pregnancy HEATHER HOWE, MD UNIVERSITY OF UTAH PULMONARY DIVISION Asthma Management in Pregnancy Effects of asthma on pregnancy outcomes Effects of pregnancy on asthma control Management
More informationHealthPartners Care Coordination Clinical Care Planning and Resource Guide ASTHMA
The following evidence based guideline was used in developing this clinical care guide: National Institute of Health (NIH National Heart, Lung, and Blood Institute (NHLBI) and American Academy of Allergy,
More informationAsthma 2015: Establishing and Maintaining Control
Asthma 2015: Establishing and Maintaining Control Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C June 16, 2015 Asthma Prevalence Approx. 26
More informationGet Healthy Stay Healthy
Asthma Management WHAT IS ASTHMA? Asthma causes swelling and inflammation in the breathing passages that lead to your lungs. When asthma flares up, the airways tighten and become narrower. This keeps the
More informationTRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder
TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationDiagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma
Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma Magnitude of Asthma - India Delhi Childhood asthma: 10.9% Adults: 8% Other Cities 3 to 18% Chhabra SK et al Ann Allergy Asthma
More informationImproving asthma outcomes though education
Improving asthma outcomes though education Segment 1 Clinical Aspects of Asthma and Long term Plan Primary Care and Asthma Most common chronic disease of childhood. Primary care providers are expected
More informationPediatric Asthma Management
Pediatric Asthma Management APRN Conference February 2016 Cheryl Kerrigan, MSN, CPNP Aimee Tiller RN, AE-C The Plan Definition Pathophysiology review Triggers & Risk Factors Incidence and Prevalence Making
More informationSources. Taking Charge of Your Asthma. Asthma Action Plan (to be completed with your doctor) UnitedHealthcare Insurance Company
Asthma Action Plan (to be completed with your doctor) Green Zone: (80 to 00% of my personal best) Peak Flow between and (00% = personal best) You can do all the things you usually do. Your asthma medicine
More informationFASENRA (benralizumab)
FASENRA (benralizumab) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
More informationInhaler Confusion. Today s Speaker Dr. Randall Brown. Director of Asthma Programs 6/7/2016. Dr. Randall Brown March 31, 2016
+ Inhaler Confusion Dr. Randall Brown March 31, 2016 + Today s Speaker Dr. Randall Brown Director of Asthma Programs Center for Managing Chronic Disease University of Michigan 1 ASTHMA ESSENTIALS IN PRIMARY
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationEnhancing Patient Care
Enhancing Patient Care I CAN control my asthma! PHYSICIAN WEB ORIENTATION COMMUNITY PEDIATRIC ASTHMA SERVICE JULY 2014 Sorry we couldn't connect in person This presentation will inform Calgary Zone physicians
More informationreslizumab (Cinqair )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationDifficult Asthma Assessment: A systematic approach
Difficult Asthma Assessment: A systematic approach Dr Naghmeh Radhakrishna Respiratory, Sleep & Allergy Physician Allergy, Asthma & Clinical Immunology Service The Alfred Hospital Melbourne, Australia
More informationAsthma. Definition. Symptoms
Asthma Definition Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some
More informationAllergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
More informationRespiratory Health. Asthma and COPD
Respiratory Health Asthma and COPD Definition of asthma Working definition by AAH 2014: Chronic lung disease Can be controlled not cured Large variation in lung function Large variation in respiratory
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationPeak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation
Peak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation PI: Brian Driver, MD Checklist Reviewed Inclusion and Exclusion Criteria Confirm pertinent exclusion criteria with PMP Engage
More informationbenralizumab (Fasenra )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationGreater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma
Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma Non-pharmacological options for ALL patients, consider at ALL stages Make sure diagnosis
More informationAsthma medications: Know your options - MayoClinic.com. Asthma medications: Know your options
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationAsthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital
Asthma Update - 2013 A/Prof. John Abisheganaden Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital Asthma A complex syndrome Multifaceted disease Heterogeneous Genetic and
More informationHow to get the most out of your medical appointments. Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital
How to get the most out of your medical appointments Center For Cardiac Fitness Pulmonary Rehab Program The Miriam Hospital Objectives Discuss who works in the typical doctors office Discuss things you
More informationTaking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP
Taking Control of Asthma Through Proper Medication Selection and the Use of Asthma Action Plans Julie M. Koehler, Pharm.D., FCCP Associate Dean for Clinical Education and External Affiliations & Professor
More informationInhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
More informationCase-Compare Impact Report
Case-Compare Impact Report October 8, 20 For CME Activity: Developed through an independent educational grant from Genentech: Moderate to Severe Persistent Asthma: A Case-Based Panel Discussion (March
More informationAsthma By Mayo Clinic staff
MayoClinic.com reprints This single copy is for your personal, noncommercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, use the reprints
More informationBecause the more you know, the better you ll feel.
ABOUT ASTHMA Because the more you know, the better you ll feel. This booklet is designed to help you understand asthma and the things you can do every day to help control symptoms. As always, talk to your
More informationInhaled Corticosteroids Drug Class Prior Authorization Protocol
Inhaled Corticosteroids Drug Class Prior Authorization Protocol Line of Business: Medi-Cal P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review
More informationAdjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older
Adjustment of Inhaled Controller Therapy of Asthma in the Yellow Zone, Based on the Inhaler Product Used in the Green Zone Age 16 Years and Older The Canadian Thoracic Society and other international asthma
More informationImproving Outcomes in the Management & Treatment of Asthma. April 21, Spring Managed Care Forum
Improving Outcomes in the Management & Treatment of Asthma April 21, 2016 2016 Spring Managed Care Forum David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health University
More informationAsthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
More information10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C
Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C Daily: Long-Term Control Corticosteroids (inhaled and systemic) Long-acting beta 2 -agonists (Serevent, Foradil) Methylxanthines
More informationBreathe Easy ACTIVITIES. A Family Guide to Living with Asthma F O R T H E K ! I D S
Breathe Easy A Family Guide to Living with Asthma ACTIVITIES FUN & EDUCATIONAL F O R T H E K! I D S What Is Asthma? Asthma is a disease of the lungs. It s a chronic (long-term) condition that affects the
More informationTHE PLANNED ASTHMA VISIT
THE PLANNED ASTHMA VISIT Rhonique Shields-Harris, MD Molly Savitz, MSN, FNP, AE-C CNHN Childhood Asthma QI MOC Learning Collaborative October 30, 2012 Childhood Asthma QI Collaborative CME Learning Objectives
More informationPresented by UIC College of Nursing
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long-acting inhalers and emergency use inhalers.
More informationChronic Obstructive Pulmonary Disease 1/18/2018
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long acting inhalers and emergency use inhalers.
More informationPresented by the California Academy of Family Physicians 2013/California Academy of Family Physicians
Family Medicine and Patient-Centered Asthma Care Presented by the California Academy of Family Physicians Faculty: Hobart Lee, MD Disclosures: Jeffrey Luther, MD, Program Director, Memorial Family Medicine
More informationDrug Class Monograph
Drug Class Monograph Class: Inhaled Corticosteroids Drugs: Aerospan (flunisolide), Advair Diskus, Advair HFA (fluticasone/salmeterol), Alvesco (ciclesonide), Arnuity Ellipta (fluticasone furoate), Asmanex
More informationThe methodology behind GINA and EPR-3 medication recommendations: Stepwise treatment in asthma
The methodology behind GINA and EPR-3 medication recommendations: Stepwise treatment in asthma Maureen George PhD RN AE-C FAAN Columbia University mg3656@cumc.columbia.edu Faculty Disclosures Maureen George
More informationBecause the more you know, the better you ll feel.
ABOUT ASTHMA Because the more you know, the better you ll feel. What You ll Find Attitudes and Beliefs Asthma What Is It? Where You ll Find It Page 4-5 This booklet is designed to help you understand asthma
More informationAsthma ASTHMA. Current Strategies for Asthma and COPD
Current Strategies for Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor of Medicine Chair, Department of Medicine University of California San Francisco (UCSF) San Francisco,
More informationUsing Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless?
Using Inhaled Corticosteroids as Needed for Asthma: giving patients relief or leaving them breathless? Lindsay Thomas, Pharm.D. PGY2 Ambulatory Care Resident Department of Pharmacotherapy and Pharmacy
More informationASTHMA BEST PRACTICES FOR SCHOOL NURSES. School Nurses November 2015
ASTHMA BEST PRACTICES FOR SCHOOL NURSES School Nurses November 2015 1 BACKGROUND AND CURRENT STATS General definitions and explanations 2 Incidence of Asthma Centers for Disease Control (CDC) - 1 in 12
More informationMDI Bonanza. Dwayne Griffin, DO
MDI Bonanza Dwayne Griffin, DO Bonanza 3. A MDI costing $200 - $500 per month SISYPHUS MDI Griffin Mountain Evolution of Deliver Systems for COPD in the US 2003 2009 2011 2013 2004 2012 2014 Prescribing
More informationDrug Prior Authorization Guideline NUCALA (mepolizumab)
Drug Prior Authorization Guideline MB9914 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Restricted to Pulmonology, Allergy, and
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP 3 Main Categories Inhaled Respiratory Drugs Binds to beta-2 receptors Relaxation of smooth muscles in the lung
More informationAsthma Management for the Athlete
Asthma Management for the Athlete Khanh Lai, MD Assistant Professor Division of Pediatric Pulmonary and Sleep Medicine University of Utah School of Medicine 2 nd Annual Sports Medicine Symposium: The Pediatric
More informationAsthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma
Asthma Pharmacotherapy 2017: Stepwise Approach to Managing Asthma Webinar for Michigan Center for Clinical Systems Improvement (Mi-CCSI) Karen Meyerson, MSN, APRN, NP-C, AE-C Director, Commercial Care
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP October 23, 2017 Learning Objectives Be able to list at least 3 major adverse effects of inhaled medications
More informationCOPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes
COPD Medications Coverage Summary Drug Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes Ventolin MDI + generics Yes Yes Ventolin Diskus NO NO Yukon Pharmacare/Chronic Disease Program
More informationPrimary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD
Primary Care Medicine: Concepts and Controversies Wed., February 17, 2010 Fiesta Americana Puerto Vallarta, Mexico Update on Asthma and COPD Talmadge E. King, Jr., M.D. Krevins Distinguished Professor
More informationPosition within the Organisation
ASTHMA TREATMENT GUIDELINES Document Description Document Type Service Application Guidelines All healthcare professionals(hcps) caring for patients with asthma Version 4.0 Ratification date September
More informationBreathe Easy. Living with Asthma
Breathe Easy Living with Asthma Got Asthma? You re Not Alone! More than 300 million people around the world have asthma. But having asthma doesn t have to limit what you can do. With education and treatment,
More informationSAMPLE. mg by mouth every day for day(s) Prednisolone. Other Medicine: Medicine Dose How long Directions
Pediatric Asthma Discharge Prescription and Short-Term Plan The doctor will fill out this form before your child is discharged. Please follow this plan until you see your usual doctor in 3 to 7 days. Hospital
More informationFoundations of Pharmacology
Pharmacologic Management of Asthma Objectives: 1. Review the physiological basis for asthma therapy 2. Discuss the differences between SABA and LABA 3. Discuss the role of inhaled and oral systemic corticosteroids
More informationAmanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ
Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute Scottsdale, AZ Financial Disclosures Advanced Practiced Advisory Board for Circassia Learning Objectives 1. Briefly
More informationAsthma Upate 2018: What s New Since the 2007 Asthma Guidelines of NAEPP?
10:50-11:50am Asthma Update 2018: What s New Since the 2007 National Asthma Guidelines? SPEAKER Christopher H. Fanta, MD Disclosures The following relationships exist related to this presentation: Christopher
More informationYour Guide to MANAGING ASTHMA
Your Guide to MANAGING ASTHMA Asthma affects more than 24 MILLION AMERICANS. It is a chronic disease that causes your airways to become inflamed, making it hard to breathe. There is no cure for asthma.
More informationAsthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
More informationClinical Practice Guideline: Asthma
Clinical Practice Guideline: Asthma INTRODUCTION A critical aspect of the diagnosis and management of asthma is the precise and periodic measurement of lung function both before and after bronchodilator
More informationGlobal Initiative for Asthma (GINA) What s new in GINA 2016?
Global Initiative for Asthma (GINA) What s new in GINA 2016? GINA Global Strategy for Asthma Management and Prevention GINA: A Brief History Established in 1993 Collaboration between NHLBI and WHO Multiple
More informationWorking Together to Better Manage Childhood Asthma
Working Together to Better Manage Childhood Asthma Bennie McWilliams, M.D. Howard Rosenblatt, M.D. Meena Ganesh, M.D. Chris Valmores, B.S.C.S.M., R.R.P.T. Carol Reagan, R.Ph. Johnny Smith Johnny is a 5
More informationComplements asthma therapy NOT a CURE for Severe. Non pharmacologic treatment of asthma. limits the ability of the airways to constrict.
Bronchial Thermoplasty Karla Provost Pulmonary and Critical Care Medicine 2015 What is Bronchial Thermoplasty Non pharmacologic treatment of asthma Outpatient procedure performed over 3 treatment sessions
More informationWhat is Severe Persistent Asthma? What is Bronchial Thermoplasty Non pharmacologic treatment of asthma
Objectives BT defined What is Severe Persistent Asthma Case Study introduction How is BT performed Pre-op, PACU and Discharge care Who does it work for the criteria for BT Brief overview of BT results
More informationEffective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017
Protocol Title: Adult Asthma Protocol Effective Date: 4/27/2016 Version: 1.0 Approval By: CCC Clinical Delivery Steering Planned Review Date: 4/27/2017 1 Purpose & Objective This protocol provides evidence-based
More informationA Visual Approach to Simplifying Respiratory Drug Regimens
Adverse Effects of Inhaled Medications A Visual Approach to Simplifying Respiratory Drug Regimens Stephanie Cheng, PharmD, MPH, BCGP June 28, 2017 Drug Category Beta 2 agonists antagonists Adverse Effects
More informationAppendix 1: Shared decision making Intervention description: Carolinas Asthma Coach
Appendix 1: Shared decision making Intervention description: Carolinas Asthma Coach Based on the platform of motivational interviewing and shared decision making, the ipad version of the Asthma Coach was
More informationReference Guide for Caring for Pediatric Patients with Asthma
Reference Guide for Caring for Pediatric Patients with Asthma Co-Chair: Nancy Cantey Banasiak, DNP, PPCNP-BC, APRN Co-Chair: Deborah Hickman, DNP, APRN-CNP, CPNP-PC, NNP-BC Asthma and Allergy SIG Members
More informationKey features and changes to these four components of asthma care include:
Guidelines for the Diagnosis and Management of Asthma in Adults Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions regarding
More informationMANAGEMENT OF ASTHMA SPRING Presented by:
MEDS@Work MANAGEMENT OF ASTHMA SPRING 2013 Presented by: Lusia Fomuso PharmD candidate 2014 Olivia Sibailly PharmD candidate 2014 Kimberly Biedka PharmD candidate 2014 Dr. Donna Bartlett PharmD CGP RPh
More informationNational Asthma Educator Certification Board Detailed Content Outline
I. THE ASTHMA CONDITION 9 20 1 30 A. Pathophysiology 4 6 0 10 1. Teach an individual with asthma and their family using simple language by illustrating the following with appropriate educational aids a.
More informationcontinuing education for pharmacists
continuing education for pharmacists Volume XXXIV, No. 12 Asthma: Approaches to Treatment and New Therapies Cortney M. Mospan, PharmD, BCACP, CGP, Assistant Professor of Pharmacy, Wingate University School
More informationExercise-Induced Bronchospasm. Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute
Exercise-Induced Bronchospasm Michael A Lucia, MD, FCCP Asst Clinical Professor, UNR School of Medicine Sierra Pulmonary & Sleep Institute EIB Episodic bronchoconstriction with exercise May be an exacerbation
More informationCOPD and Asthma Update. April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute
COPD and Asthma Update April 29 th, 2017 Rachel M Taliercio, DO Staff, Respiratory Institute What we ll be talking about COPD: diagnosis, management of stable COPD, COPD exacerbations Asthma: diagnosis,
More informationCOPD Medicine. No one ever showed me how to use this. Wendy Happel; RRT, COPD Educator Krystal Fedoris; RRT-NPS, BA, COPD Educator
Medicine. No one ever showed me how to use this. Wendy Happel; RRT, Educator Krystal Fedoris; RRT-NPS, BA, Educator 1 Taking prescriptions correctly Taking prescriptions can be a challenge Busy schedules
More informationTreatment Options for Complicated/Severe Asthma. Henry J. Kanarek, MD Kanarek Allergy Asthma Immunology
Treatment Options for Complicated/Severe Asthma Henry J. Kanarek, MD Kanarek Allergy Asthma Immunology www.kallergy.com 913-451-8555 Asthma Epidemiology World Health Organization, Asthma is one of the
More informationDiagnosis and Management of Asthma
Supporting Evidence: Diagnosis and Management of Asthma The subdivision of this section is: Appendix B Tables Copyright 2016 by 1 Eleventh Edition/December 2016 Appendix B Asthma Summary Tables Class:
More informationAsthma in Pediatric Patients. DanThuy Dao, D.O., FAAP. Disclosures. None
Asthma in Pediatric Patients DanThuy Dao, D.O., FAAP Disclosures None Objectives 1. Discuss the evaluation and management of asthma in a pediatric patient 2. Accurately assess asthma severity and level
More informationYellow Zone Practice Parameters for Management of Acute Loss of Asthma Control
Yellow Zone Practice Parameters for Management of Acute Loss of Asthma Control Asthma Educator Sharing Day Lansing, MI October 28, 2016 Karen Meyerson, MSN, APRN, NP-C, AE-C Director, Commercial Care Management
More informationHome Management Plan. Cover Page
Home Management Plan Cover Page What is Asthma? Asthma is a chronic disease of the lungs caused by swelling and irritation in the lining of airways Tightness of the airway muscles Excess mucus in the airways
More informationyour breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems.
MEDICATION GUIDE ADVAIR DISKUS [ad vair disk us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation What is the most important information I should know about ADVAIR DISKUS?
More informationAppendix D. Sample Draft Clinical Guidelines
Appendix D. Sample Draft Clinical Guidelines 95 The sample guideline Asthma Chronic Care was drafted by Ronald M. Shansky, M.D., M.P.H., and is presented here in draft form. Once adopted by the National
More informationNucala (mepolizumab injection for subcutaneous use)
Nucala (mepolizumab injection for subcutaneous use) Policy Number: 5.01.612 Last Review: 01/2018 Origination: 02/2016 Next Review: 02/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will
More informationDiagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
More informationBiologic Agents in the treatment of Severe Asthma
Biologic Agents in the treatment of Severe Asthma Daniel L Maxwell, D.O., FACOI, FAASM Clinical Assistant Professor of Medicine Michigan State University College of Osteopathic Medicine College of Human
More informationQuestion I was one of the first dry power devices available in the US Flovent, Serevent and Advair are all available in this device
What Device am I Class Side Effects History Potpourri Monitoring Tools 10 10 10 10 10 20 20 20 20 20 30 30 30 30 30 40 40 40 40 40 50 50 50 50 50 WHAT KIND OF DEVICE AM I? I was one of the first dry power
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Fasenra) Reference Number: CP.PHAR.## Effective Date: 01.16.18 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy
More information